Cel Sci CORP Form 4 insider transactions

Robert Eugene Watson, a Director of Cel Sci Corp, received 110,000 shares of common stock on August 14, 2026.

Bruno Jean-Marie Baillavoine, a Director of Cel Sci Corp, received 110,000 shares of common stock on August 14, 2026.

John Cipriano, Senior Vice President of Cel Sci Corp, received 80,000 shares of common stock on August 14, 2026.

Eyal Talor, Chief Scientific Officer of Cel Sci Corp, received 250,000 shares of common stock on August 14, 2026.

Patricia B Prichep, Chief Financial Officer of Cel Sci Corp, received 225,000 shares of common stock on August 14, 2026.

Geert R Kersten, Chief Executive Officer and a Director of Cel Sci Corp, received 300,000 shares of common stock on August 14, 2026.

CEL SCI CORP reports that Chief Scientific Officer Eyal Talor acquired 2,307 shares of common stock on June 30, 2026.

CEL SCI CORP reports that Chief Financial Officer Patricia Prichep acquired 4,125 shares of common stock on June 30, 2026.

Cel Sci Corp reports insider Geert Kersten acquired 5,192 shares of common stock on June 30, 2026.

CEL SCI CORP reports that CEO Geert Kersten acquired 300,000 shares of common stock through a trust on May 14, 2026.

CEL SCI Corp CEO Geert Kersten acquired 100,000 shares of common stock directly from the company.

CEL SCI's Chief Scientific Officer, Eyal Talor, acquired 747 shares of common stock at $3.21 per share, increasing direct ownership to 7,011 shares.

CEL-SCI Corporation's Chief Financial Officer, Patricia Prichep, acquired 1,336 shares of common stock at $3.21 per share.

CEL-SCI Corp's CEO, Geert R. Kersten, acquired 1,682 shares of common stock at $3.21 per share, increasing his direct beneficial ownership.

CEL-SCI Corp's CEO and Director, Geert Kersten, acquired 38,023 shares of common stock at $5.26 per share.

CEL-SCI's Chief Scientific Officer, Eyal Talor, has filed a Form 4 indicating a planned acquisition of 456 shares of common stock at $5.26 per share on December 31, 2025.

CEL-SCI Corporation's CFO, Patricia B. Prichep, reported a planned acquisition of 815 common shares under a Rule 10b5-1 plan.

CEL-SCI Corp's CEO, Geert R. Kersten, acquired 998 shares of common stock at $5.26 per share, increasing his direct beneficial ownership to 82,792 shares.

CEL SCI Corp's CEO, Geert R. Kersten, purchased 8,389 shares of common stock directly from the company at $5.96 per share, increasing his beneficial ownership to 81,794 shares.

CEL-SCI Corp.'s Chief Scientific Officer, Eyal Talor, acquired 260 shares of common stock at $9.20 per share.

CEL-SCI Corporation's Chief Financial Officer, Patricia B. Prichep, acquired 466 shares of common stock at $9.20 per share on September 30, 2025, increasing her direct beneficial ownership to 11,213 shares under a Rule 10b5-1 plan.

CEL-SCI Corp's CEO, Geert R. Kersten, acquired 570 shares of common stock at $9.20 per share, increasing his direct beneficial ownership to 73,405 shares.

CEL SCI Corporation's Director and 10% owner, Robert Eugene Watson, was granted 4,000 stock options with an exercise price of $8.20, vesting over three years.

CEL SCI Corp Director Bruno Baillavoine was granted 4,000 stock options with an exercise price of $8.20, vesting over three years.

CEL SCI Corp's Senior Vice President, John Cipriano, was granted 7,500 stock options with an exercise price of $8.20, vesting over three years.

CEL-SCI Corporation's Chief Scientific Officer, Eyal Talor, was granted 15,000 stock options with an exercise price of $8.20, vesting over three years.

CEL-SCI Corporation's Chief Financial Officer, Patricia B. Prichep, was granted 12,000 stock options with an exercise price of $8.20 per share, vesting over three years.

CEL-SCI Corporation's CEO, Geert R. Kersten, was granted 25,000 stock options with an exercise price of $8.20, vesting over three years.

CEL SCI Corporation Director Robert Watson acquired 2,919 shares of the company's common stock, increasing his direct beneficial ownership.

CEL SCI Corporation's CEO and Director, Geert Kersten, acquired 29,197 shares of common stock for $6.85 per share, increasing his direct beneficial ownership to 72,835 shares.